Effect of hormone replacement therapy on nitric oxide bioactivity and monocyte chemoattractant protein-1 levels

International Journal of Cardiology

Volumn 81, Issue 1, 2001, Pages 43-50

  Koh, Kwang Kon ^a   Won Son, Ji ^a   Yeal Ahn, Jeong ^a   Lee, Seon Kyu ^a   Young Hwang, Hee ^a   Sung Kim, Dae ^a   Kyu Jin, Dong ^a   Hoon Ahn, Tae ^a   Kyun Shin, Eak ^a  

^a Gachon University College of Medicine   (South Korea)

Author keywords

Atherosclerosis; Endothelium; Hormone replacement therapy; Menopause; Monocyte chemoattractant protein; Nitric oxide bioactivity

Indexed keywords

CONJUGATED ESTROGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PROGESTERONE;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART PROTECTION; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; HYPEREMIA; INFLAMMATORY DISEASE; MALE; NORMAL HUMAN; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN BLOOD LEVEL;

AGE FACTORS; ANALYSIS OF VARIANCE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CHEMOKINE CCL2; ENDOTHELIUM, VASCULAR; ESTROGENS, CONJUGATED (USP); FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; POSTMENOPAUSE; PREMENOPAUSE; PROGESTERONE; SEX FACTORS;

EID: 0034749552     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(01)00527-7     Document Type: Article

References (34)

1. Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study
2. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women
3. The effect of estrogen and cholesterol-lowering therapies on vascular function in hypercholesterolemic postmenopausal women
4. Effects of estrogen and vitamin E therapies on vascular function in postmenopausal women
5. Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women
6. Atherosclerosis - An inflammatory disease
7. Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates
8. Monocyte chemoattrractant protein-1 in human atheromatous plaques
9. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice
10. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B
11. Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction
12. Atherosclerosis: Basic mechanisms. Oxidation, inflammation and genetics
13. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells
14. NO inhibits cytokine-induced iNOS expression and NF-kB activation by interfering with phosphorylation and degradation of IkB-α
15. Estrogen increases endothelial nitric oxide by a receptor-mediated system
16. 2+ mobilization
17. Estrogen modulation of JE/monocygte chemoattractant protein-1 mRNA expression in murine macrophages
18. Estradiol suppresses MCP-1 expression in vivo. Implications for atherosclerosis
19. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
20. Mechanism by which quinapril improves vascular function in coronary artery disease
21. Non-invasive measurement of human endothelium dependent arterial responses: Accuracy and reproducibility
22. Effect of conjugated estrogen on peripheral flow-mediated vasodilation in postmenopausal women
23. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women
24. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function
25. Monocyte chemoattrractant protein-1 but not tumor necrosis factor-α is correlated with monocyte infiltration in mouse lipid lesions
26. Direct demonstration of P-selectin- and VCAM-1-dependent monocuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice
27. Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries
28. Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo. Possible mechanisms for gender differences in atherosclerosis
29. Inhibition of NO synthesis induces inflammatory changes and monocyte chemoattractant protein-1 expression in rat hearts and vessels
30. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells
31. Effects of hormone replacement therapy on serum monocyte chemoattractant protein-1 in postmenopausal women
32. Adenovirus-mediated overexpression of c-jun and c-fos induces intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human endothelial cells
33. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins
34. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial